미국의 구조적 심장 영상 시장 규모, 점유율, 동향 분석 보고서 : 모달리티별, 수술별, 용도별, 최종 용도별, 부문 예측(2025-2030년)

U.S. Structural Heart Imaging Market Trends:

The U.S. structural heart imaging market size was estimated at USD 2.58 billion in 2024 and is expected to grow at a CAGR of 5.9% from 2025 to 2030. The rising prevalence of structural heart diseases, an aging population, and increasing adoption of minimally invasive procedures like TAVR and TMVR. Technological advancements such as 3D/4D echocardiography, AI-powered diagnostics, and fusion imaging have improved accuracy and efficiency in diagnosis and treatment planning. Expanding hospital infrastructure, increased awareness of early diagnosis, and collaborations between imaging companies and healthcare providers further fuel market growth.

The expansion of structural heart imaging in the U.S. is primarily driven by the growing prevalence of heart diseases and an increasing emphasis on preventive health checkups. Structural heart diseases, such as aortic stenosis, mitral regurgitation, and congenital heart defects, are becoming more common, particularly among the aging population, which is more vulnerable to these conditions. Early detection and accurate diagnosis are essential for managing these diseases effectively, fueling the demand for advanced imaging technologies. Simultaneously, patients are increasingly aware of the importance of preventive healthcare. People are increasingly opting for regular health screenings to detect potential cardiovascular issues before they become severe, which has led to a greater reliance on structural heart imaging solutions.

The presence of major manufacturers, such as Siemens Healthineers, GE Healthcare, and Koninklijke Philips N.V., is significantly driving market growth in the U.S. These industry leaders are consistently innovating and introducing advanced imaging products to meet the growing demand for accurate and efficient diagnostic solutions. For instance, in August 2024, Siemens Healthineers received FDA clearance for the ACUSON Origin, an advanced cardiovascular ultrasound system integrated with artificial intelligence (AI) capabilities. This advanced system is designed to enhance diagnostic accuracy and streamline workflows, demonstrating the industry's focus on leveraging AI to improve imaging outcomes. The continuous efforts of these key players to develop and commercialize new technologies not only cater to the rising prevalence of structural heart diseases but also strengthen the market's growth by offering healthcare providers state-of-the-art tools for patient care.

U.S. Structural Heart Imaging Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 - 2030. For the purpose of this study, Grand View Research has segmented the U.S. structural heart imaging market report on the basis of modality, procedure, application, and end-use:

• Modality Outlook (Revenue, USD Million, 2018 - 2030)
• Echocardiogram
• Angiogram
• CT
• MRI
• Nuclear Imaging
• Other Modalities
• Procedure Outlook (Revenue, USD Million, 2018 - 2030)
• Transcatheter Aortic Valve Replacement (TAVR)
• Surgical Aortic Valve Replacement (SAVR)
• Transcatheter Mitral Valve Repair (TMVR)
• Left Atrial Appendage Closure (LAAC)
• Tricuspid Valve Replacement and Repair
• Paravalvular Leak Detection and Repair
• Annuloplasty
• Valvuloplasty
• Other Structural Heart Procedures
• Application Outlook (Revenue, USD Million, 2018 - 2030)
• Diagnostic Imaging
• Interventional Cardiology
• End-use Outlook (Revenue, USD Million, 2018 - 2030)
• Hospitals & Clinics
• Ambulatory Surgical Centers
• Diagnostic Imaging Centers
• Other End Use

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Modality
  • 1.1.2. Procedure
  • 1.1.3. Application
  • 1.1.4. End use
  • 1.1.5. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Modality outlook
  • 2.2.2. Procedure outlook
  • 2.2.3. Application outlook
  • 2.2.4. End use outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Structural Heart Imaging Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Industry Value Chain Analysis
  • 3.3.1. Reimbursement framework
• 3.4. Market Dynamics
  • 3.4.1. Market driver analysis
    • 3.4.1.1. Growing prevalence of cardiac diseases
    • 3.4.1.2. Technological advancements
    • 3.4.1.3. Increasing adoption of minimally invasive procedures
  • 3.4.2. Market restraint analysis
    • 3.4.2.1. High cost of advanced imaging systems
    • 3.4.2.2. Stringent regulatory approvals
• 3.5. U.S. Structural Heart Imaging Market Analysis Tools
  • 3.5.1. Industry Analysis - Porter's
    • 3.5.1.1. Supplier power
    • 3.5.1.2. Buyer power
    • 3.5.1.3. Substitution threat
    • 3.5.1.4. Threat of new entrant
    • 3.5.1.5. Competitive rivalry
  • 3.5.2. PESTEL Analysis
    • 3.5.2.1. Political landscape
    • 3.5.2.2. Technological landscape
    • 3.5.2.3. Economic landscape

Chapter 4. U.S. Structural Heart Imaging Market: Modality Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Structural Heart Imaging Modality Market Movement Analysis
• 4.3. U.S. Structural Heart Imaging Market Size & Trend Analysis, by Modality, 2018 - 2030 (USD Million)
• 4.4. Echocardiogram
  • 4.4.1. Echocardiogram market estimates and forecast 2018 - 2030 (USD Million)
• 4.5. Angiogram
  • 4.5.1. Angiogram market estimates and forecast 2018 - 2030 (USD Million)
• 4.6. CT
  • 4.6.1. CT market estimates and forecast 2018 - 2030 (USD Million)
• 4.7. MRI
  • 4.7.1. MRI market estimates and forecast 2018 - 2030 (USD Million)
• 4.8. Nuclear Imaging
  • 4.8.1. Nuclear imaging market estimates and forecast 2018 - 2030 (USD Million)
• 4.9. Other Modalities
  • 4.9.1. Other modalities market estimates and forecast 2018 - 2030 (USD Million)

Chapter 5. U.S. Structural Heart Imaging Market: Procedure Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Structural Heart Imaging Procedure Market Movement Analysis
• 5.3. U.S. Structural Heart Imaging Market Size & Trend Analysis, by Procedure, 2018 - 2030 (USD Million)
• 5.4. Transcatheter Aortic Valve Replacement (TAVR)
  • 5.4.1. Transcatheter Aortic Valve Replacement (TAVR) market estimates and forecast 2018 - 2030 (USD Million)
• 5.5. Surgical Aortic Valve Replacement (SAVR)
  • 5.5.1. Surgical Aortic Valve Replacement (SAVR) market estimates and forecast 2018 - 2030 (USD Million)
• 5.6. Transcatheter Mitral Valve Repair (TMVR)
  • 5.6.1. Transcatheter Mitral Valve Repair (TMVR) market estimates and forecast 2018 - 2030 (USD Million)
• 5.7. Left Atrial Appendage Closure (LAAC)
  • 5.7.1. Left Atrial Appendage Closure (LAAC) market estimates and forecast 2018 - 2030 (USD Million)
• 5.8. Tricuspid Valve Replacement and Repair
  • 5.8.1. Tricuspid Valve Replacement and Repair market estimates and forecast 2018 - 2030 (USD Million)
• 5.9. Paravalvular Leak Detection and Repair
  • 5.9.1. Paravalvular Leak Detection and Repair market estimates and forecast 2018 - 2030 (USD Million)
• 5.10. Annuloplasty
  • 5.10.1. Annuloplasty market estimates and forecast 2018 - 2030 (USD Million)
• 5.11. Valvuloplasty
  • 5.11.1. Valvuloplasty market estimates and forecast 2018 - 2030 (USD Million)
• 5.12. Other Structural Heart Procedures
  • 5.12.1. Other Structural Heart Procedures market estimates and forecast 2018 - 2030 (USD Million)

Chapter 6. U.S. Structural Heart Imaging Market: Application Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. Structural Heart Imaging Application Market Movement Analysis
• 6.3. U.S. Structural Heart Imaging Market Size & Trend Analysis, by Application, 2018 - 2030 (USD Million)
• 6.4. Diagnostic Imaging
  • 6.4.1. Diagnostic imaging market estimates and forecasts 2018 - 2030 (USD Million)
• 6.5. Interventional Cardiology
  • 6.5.1. Interventional cardiology market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 7. U.S. Structural Heart Imaging Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. U.S. Structural Heart Imaging End Use Market Movement Analysis
• 7.3. U.S. Structural Heart Imaging Market Size & Trend Analysis, by End Use, 2018 - 2030 (USD Million)
• 7.4. Hospitals & clinics
  • 7.4.1. Hospitals & clinics estimates and forecast 2018 - 2030 (USD Million)
• 7.5. Ambulatory Surgical Centers
  • 7.5.1. Ambulatory surgical centers market estimates and forecast 2018 - 2030 (USD Million)
• 7.6. Diagnostic Imaging Centers
  • 7.6.1. Diagnostic imaging centers market estimates and forecast 2018 - 2030 (USD Million)
• 7.7. Other end use
  • 7.7.1. Other end use market estimates and forecast 2018 - 2030 (USD million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Key company market share analysis, 2024
• 8.4. Company Position Analysis
• 8.5. Company Categorization (Emerging Players, Innovators and Leaders
• 8.6. Company Profiles
  • 8.6.1. Siemens Healthineers
    • 8.6.1.1. Company overview
    • 8.6.1.2. Financial performance
    • 8.6.1.3. Product benchmarking
    • 8.6.1.4. Strategic initiatives
  • 8.6.2. GE Healthcare
    • 8.6.2.1. Company overview
    • 8.6.2.2. Financial performance
    • 8.6.2.3. Product benchmarking
    • 8.6.2.4. Strategic initiatives
  • 8.6.3. Koninklijke Philips N.V.
    • 8.6.3.1. Company overview
    • 8.6.3.2. Financial performance
    • 8.6.3.3. Product benchmarking
    • 8.6.3.4. Strategic initiatives
  • 8.6.4. Canon Medical Systems
    • 8.6.4.1. Company overview
    • 8.6.4.2. Financial performance
    • 8.6.4.3. Product benchmarking
    • 8.6.4.4. Strategic initiatives
  • 8.6.5. Fujifilm Holdings Corporation
    • 8.6.5.1. Company overview
    • 8.6.5.2. Financial performance
    • 8.6.5.3. Product benchmarking
    • 8.6.5.4. Strategic initiatives
  • 8.6.6. Shanghai United Imaging Healthcare Co., LTD
    • 8.6.6.1. Company overview
    • 8.6.6.2. Financial performance
    • 8.6.6.3. Product benchmarking
    • 8.6.6.4. Strategic initiatives
  • 8.6.7. Abbott
    • 8.6.7.1. Company overview
    • 8.6.7.2. Financial performance
    • 8.6.7.3. Product benchmarking
    • 8.6.7.4. Strategic initiatives
  • 8.6.8. Terumo Corporation
    • 8.6.8.1. Company overview
    • 8.6.8.2. Financial performance
    • 8.6.8.3. Product benchmarking
    • 8.6.8.4. Strategic initiatives
  • 8.6.9. Samsung Medison Co., Ltd.
    • 8.6.9.1. Company overview
    • 8.6.9.2. Financial performance
    • 8.6.9.3. Product benchmarking
    • 8.6.9.4. Strategic initiatives
  • 8.6.10. Lepu Medical Technology
    • 8.6.10.1. Company overview
    • 8.6.10.2. Financial performance
    • 8.6.10.3. Product benchmarking
    • 8.6.10.4. Strategic initiatives